Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Incompatibility between the philips aed models fr3 and frx defribrillators and covidien medi-trace cadence and kendall defibrillation electrodes. these electrodes will not connect with philips fr3 and frx aed units and in the case of the use of covidien defibrillation electrodes with the philips fr3 aed units could result in a delay of therapy. the frx aed unit requires the pads to be pre-connected and will issue a continuous alarm chirp to alert the user that the proper pads are not connected to the unit prior to use.
“If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.